Bromide

Bromide

SCHEMBL5140263

Br.Clc1ccc2[nH]c(CN(Cc3ccc(CNCc4ccccn4)cc3)C3CCCc4cccnc43)nc2c1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.53
CXCR4 P61073 20/20 0.83
CYP2D6 P10635 2/20 0.58
CYP3A4 P08684 1/20 0.58
DRD2 P14416 1/20 0.53
OPRM1 P35372 1/20 0.53
KCNH2 Q12809 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4068206 0.99 CXCR4 (0.84) CXCR4CYP2D6CYP3A4CHRM2DRD2
Bromide SCHEMBL4544117 0.92 CXCR4 (0.98) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL29823518 0.91 CXCR4 (1.00) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL1878773 0.91 CXCR4 (1.00) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL4073554 0.90 CXCR4 (0.84) CXCR4CYP2D6CYP3A4CHRM2DRD2
Bromide SCHEMBL1897567 0.89 CXCR4 (0.81) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL4070102 0.88 CXCR4 (0.81) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL4250741 0.88 CXCR4 (0.81) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL2507349 0.88 CXCR4 (0.83) CXCR4CYP2D6CYP3A4CHRM2DRD2
SCHEMBL29823655 0.88 CXCR4 (0.83) CXCR4CYP2D6CYP3A4CHRM2DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7396840-B2 Chemokine receptor binding heterocyclic compounds GENZYME CORPORATION (US) 2008-07-08 US disclosed